Latest update April 5th, 2026 12:45 AM
Latest News
- Bankrupt, lack of experience and faced with mounting lawsuits – Lindsayca awarded multi-million U.S. contract in Guyana
- Crypto, Cartels, and Collusion: GI-TOC Exposes Guyana as the Lifeblood of Venezuela’s Gold Underworld
- Kidnapping accused killed in crash on Mandela Avenue
- Iran rejects Trump’s ‘helpless, stupid’ 48-hour ultimatum
- U.S. deportation case against ‘Melly Mel’ terminated
GBTI throws support behind major Sickle Cell major project
A sample being taken from a
new-born baby
The Guyana Bank for Trade and Industry Limited [GBTI] has been making inroads into the health sector in Guyana. Support in this regard has translated to the erection of a billboard and adopting the counselling room in the Guyana Foundation Sunrise Centre in Essequibo.
The programme is to bring awareness and to sensitize the public to the scourge of suicide. It is also to being supportive efforts to ensure healthy babies are born in Guyana.
The Bank has seen it fit to partner with two doctors – Dr. Pheona Mohamed-Rambaran, Director of Medical Laboratory, and Dr. Bibi Alladin-Karan, Paediatric Resident, who are attached to the Georgetown Public Hospital Corporation (GPHC). They are currently undertaking a pilot project called “New-Born Screening”.
This pilot project has been running since July 1, last year and will continue to September 30, 2017. It and will see 3,200 new-born infants being tested for the prevalence of Sickle Cell Anaemia (SCA) and Congenital Hypothyroidism (CH) at the GPHC. To date, some 3,000 infants have been tested for these diseases.
Dr. Alladin-Karan noted that because of the efforts placed by the bank in this project they have saved a number of babies’ lives from SCA and CH. Babies born with the Sickle Cell trait are only expected to live to about the age of 25-30 years old if treatment is not administered.
Babies born with the trait of CH could potentially develop mental disorders, limb and joint impairments and other such disabilities that can affect them as they grow and develop. This, she said, is why screening for these two diseases is necessary and should form a part of the routine tests that are carried out on babies when they are born.
Dr. Alladin-Karan further noted that if the new-borns are tested and if these traits are picked up from that stage, there are treatments that can be administered to improve the quality of life for those new-borns so that they develop less complications later on in life.
At present, Dr. Alladin-Karan stated that once the mother’s consent is given, samples are taken at the GPHC, and then sent to the Children’s Health Eastern Ontario laboratory in Canada for testing to be done. A sample only requires a prick of the baby’s foot as just a small drop of blood is required.
Dr. Alladin-Karan noted that upon approaching GBTI, she was immediately granted funding. The Bank took cognisance of the fact that a research project such as this one can be beneficial to all Guyanese. Guyana, Jamaica, Trinidad and Tobago and the Bahamas are among the first Caribbean countries to pilot a study of this nature.
It is hoped that once the pilot project is completed that comprehensive sensitization and awareness campaigns will be done along with an advocacy for sustainability of this project which would then see the implementation of same by next year.
GBTI also intends to forge ahead with this partnership so that in due time, the testing can be done locally.
Discover more from Kaieteur News
Subscribe to get the latest posts sent to your email.
Similar Articles
THE BLUNT OF THE DAY
Sports
Features/Columnists
Sir. Ronald Sanders
The GHK Lall Column
Weekend Cartoon
